The research program at Great Plains Health is an affiliate of the University of Nebraska Medical Center. Great Plains Health works with them to open new studies and continues to follow-up on individuals who were affiliated with the Alliance for Clinical Trials in the past. In addition, Great Plains Health keeps all regulatory files current for all studies. Studies available vary as to diagnosis, with breast, lung, colon, and prostate being the most commonly available studies. We also enroll patients in the Lymphoma Tumor Registry and the Breast Cancer Collaborative Registry, which allows continued research in these specific areas of cancer. We continue to have available trials open with Cancer Alliance of Nebraska, which provides a number of trials for all cancers available to our patients to be enrolled in providing they meet the inclusion criteria. The Lymphoma Study Group Registry and Tissue Bank through the University of Nebraska Medical Center is another group with which the research coordinator works to follow patients diagnosed with lymphoma. In 2018, thirteen new patients were added to the Lymphoma Study Group, and we continue to screen individuals and follow approximately 250 patients every six months to one year for the group. Twenty-two patients were enrolled in studies/registries in 2018 at the Callahan Cancer Center at Great Plains Health, and we had two patients who we referred to the University of Colorado-Cancer Center Anschutz and enrolled in clinical trials there. These studies consisted of breast cancer patients, lymphoma patients, and head and neck cancer patients. We continue to follow patients who have been enrolled in past clinical trials until their time of death. We are proud of the contributions we are making to research at the Callahan Cancer Center and the accessibility for participation in the leading-edge treatments for our patients. Overall, our Cancer Center enrolled 24 patients in registries and trials in 2018, and that brings us to a six percent accrual, surpassing the four percent required for CoC commendation. Each year, we continue to focus on breast cancer patients, and we are very excited to provide cutting- edge treatments and registries for those patients.
Currently, we enroll breast cancer patients in the Breast Cancer Collaborative Registry, and the Breast Cancer Focus Group Study, which are both affiliated with the University of Nebraska Medical Center. We continue to follow nine breast cancer patients yearly who were enrolled in the 2009 Wyeth 3004 Study, which was turned over to PUMA in 2014.
2018 brought a new electronic medical record system, a new EMR, Epic, at Great Plains Health and the Callahan Cancer Center. Implementation of EPIC brought some challenges with learning a new system, but overall, it's an excellent medical record that makes available to all providers the most current information on our patients. Clinical Research patients are identified for all providers and staff when working with the patient, a great feature in the EPIC system. The Callahan Cancer Center continued in 2019 the work our clinical research and registries do for our patients and the advancement of cancer care in our region. The diagnosis of cancer shakes the world of each and every patient who hears those words. Our goal is to inspire health and healing, and provide support and guidance during their cancer journey. If that journey leads them in the direction of a clinical trial, then our team is here to help with the advancement of cancer care.
Lisa Kosmacek, RN BSN Clinical research coordinator
Sheila Markley, RN BSN CBCN Nurse navigator
5
2 0 1 9 A N N U A L R E P O R T
Made with FlippingBook - professional solution for displaying marketing and sales documents online